Alle Fotos(1)

Dokumente

D8942

Dichlorophenyl-ABA

Name: Dichlorophenyl-ABA
Brand: SIGMA

≥98% (HPLC), solid

Synonym(e):

2-[(3,5-Dichlorophenyl)amino]benzoic acid

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):

C₁₃H₉Cl₂NO₂

CAS-Nummer:

18201-65-5

Molekulargewicht:

282.12

MDL-Nummer:

MFCD07370135

UNSPSC-Code:

12352200

PubChem Substanz-ID:

24724469

Assay

≥98% (HPLC)

Form

solid

Farbe

white

Löslichkeit

DMSO: ~18 mg/mL at ~60 °C

Lagertemp.

2-8°C

SMILES String

OC(=O)c1ccccc1Nc2cc(Cl)cc(Cl)c2

InChI

1S/C13H9Cl2NO2/c14-8-5-9(15)7-10(6-8)16-12-4-2-1-3-11(12)13(17)18/h1-7,16H,(H,17,18)

InChIKey

FNGSQOJHNAYHAT-UHFFFAOYSA-N

Angaben zum Gen

human ... TTR(7276)

Biochem./physiol. Wirkung

Inhibitor of transthyretin amyloid fibril formation in vitro.

Piktogramme

GHS07

Signalwort

Warning

H-Sätze

H315,H319,H335

P-Sätze

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Gefahreneinstufungen

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Zielorgane

Respiratory system

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

dust mask type N95 (US), Eyeshields, Gloves

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture.

Natàlia Reixach et al.

Proceedings of the National Academy of Sciences of the United States of America, 101(9), 2817-2822 (2004-02-26)

The transthyretin (TTR) amyloidoses are human diseases in which the misfolded TTR protein aggregates in tissues with subsequent visceral, peripheral, and autonomic nerve dysfunction. Recent reports have stressed the importance of oligomeric intermediates as major cytotoxic species in various forms

Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

Per Hammarström et al.

Science (New York, N.Y.), 299(5607), 713-716 (2003-02-01)

Genetic evidence suggests that inhibition of amyloid fibril formation by small molecules should be effective against amyloid diseases. Known amyloid inhibitors appear to function by shifting the aggregation equilibrium away from the amyloid state. Here, we describe a series of

Protein aggregation and neurodegenerative disease.

Christopher A Ross et al.

Nature medicine, 10 Suppl, S10-S17 (2004-07-24)

Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS) and prion diseases are increasingly being realized to have common cellular and molecular mechanisms including protein aggregation and inclusion body formation. The aggregates

An Assay for Screening Potential Drug Candidates for Alzheimer's Disease That Act as Chaperones of the Transthyretin and Amyloid-β Peptides Interaction.

Ellen Y Cotrina et al.

Chemistry (Weinheim an der Bergstrasse, Germany), 26(72), 17462-17469 (2020-08-08)

The protein transthyretin (TTR) modulates amyloid-β (Aβ) peptides deposition and processing and this physiological effect is further enhanced by treatment with iododiflunisal (IDIF), a small-molecule compound (SMC) with TTR tetramer stabilization properties, which behaves as chaperone of the complex. This

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.